A common target of both the ATM-CHK2 and ATR-CHK1 signaling cascades is the tumor suppressor protein p53, a transcription factor mainly involved in the maintenance of genomic stability whose loss or mutation is responsible for tumor susceptibility [5,7,8,9,10]. Here, TP53 is linked to neoplasm.